哮喘：从表型到个性化医疗。
Asthma: From Phenotypes to Personalized Medicine.
作者信息
Bakakos Petros
机构信息
1st University Department of Respiratory Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
出版信息
J Pers Med. 2022 Nov 6;12(11):1853. doi: 10.3390/jpm12111853.
Abstract
Asthma is a heterogeneous disease of the airways with a high prevalence worldwide characterized by chronic inflammation [...].
摘要
哮喘是一种气道的异质性疾病，在全球范围内具有高患病率，其特征为慢性炎症[...]。
相似文献
1
Asthma: From Phenotypes to Personalized Medicine.
J Pers Med. 2022 Nov 6;12(11):1853. doi: 10.3390/jpm12111853.
2
Applying personalized medicine to adult severe asthma.
Allergy Asthma Proc. 2021 Jan 1;42(1):e8-e16. doi: 10.2500/aap.2021.42.200100.
3
[Asthma in clinical practice: from inflammatory phenotypes to personalized treatment].
Rev Med Liege. 2022 May;77(5-6):289-294.
4
Phenotypes and endotypes of adult asthma: Moving toward precision medicine.
J Allergy Clin Immunol. 2019 Jul;144(1):1-12. doi: 10.1016/j.jaci.2019.05.031.
5
Defining phenotypes in asthma: a step towards personalized medicine.
Drugs. 2014 May;74(7):719-28. doi: 10.1007/s40265-014-0213-9.
6
The role of the small airways in the pathophysiology of asthma and chronic obstructive pulmonary disease.
Ther Adv Respir Dis. 2015 Dec;9(6):281-93. doi: 10.1177/1753465815588064. Epub 2015 Jun 2.
7
Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
Respir Res. 2015 Nov 17;16:142. doi: 10.1186/s12931-015-0299-y.
8
Asthma phenotypes: the intriguing selective intervention with Montelukast.
Asthma Res Pract. 2016 Aug 12;2:11. doi: 10.1186/s40733-016-0026-6. eCollection 2016.
9
The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies.
Expert Rev Respir Med. 2018 Sep;12(9):733-743. doi: 10.1080/17476348.2018.1505507. Epub 2018 Aug 7.
10
Needs for Systems Approaches to Better Treat Individuals With Severe Asthma: Predicting Phenotypes and Responses to Treatments.
Front Med (Lausanne). 2020 Mar 31;7:98. doi: 10.3389/fmed.2020.00098. eCollection 2020.
本文引用的文献
1
Asthma and Tobacco Smoking.
J Pers Med. 2022 Jul 27;12(8):1231. doi: 10.3390/jpm12081231.
2
Allergic Asthma in the Era of Personalized Medicine.
J Pers Med. 2022 Jul 18;12(7):1162. doi: 10.3390/jpm12071162.
3
Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice.
J Pers Med. 2022 Jun 30;12(7):1093. doi: 10.3390/jpm12071093.
4
Biologic Therapies in Pediatric Asthma.
J Pers Med. 2022 Jun 18;12(6):999. doi: 10.3390/jpm12060999.
5
Biological Therapy of Severe Asthma and Nasal Polyps.
J Pers Med. 2022 Jun 16;12(6):976. doi: 10.3390/jpm12060976.
6
Paucigranulocytic Asthma: Potential Pathogenetic Mechanisms, Clinical Features and Therapeutic Management.
J Pers Med. 2022 May 23;12(5):850. doi: 10.3390/jpm12050850.
7
Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions.
J Pers Med. 2022 Apr 28;12(5):708. doi: 10.3390/jpm12050708.
8
Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity.
J Pers Med. 2022 Mar 21;12(3):504. doi: 10.3390/jpm12030504.
9
Asthma with Fixed Airflow Obstruction: From Fixed to Personalized Approach.
J Pers Med. 2022 Feb 23;12(3):333. doi: 10.3390/jpm12030333.
10
Unraveling the Relationship of Asthma and COVID-19.
J Pers Med. 2021 Dec 16;11(12):1374. doi: 10.3390/jpm11121374.
Zotero 插件